Enteric Empty Capsules Market Forecast 2023 - 2031
Report ID : CBI_1313 |
| Published Date:
| Format :
| Base Year: | 2022 |
|---|---|
| CAGR: | 8.3% |
| Forecast Year: | 2023 - 2031 |
| Revenue 2022: | $73.31 Mn |
| Revenue 2023: | $78.47 Mn |
| Revenue 2031: | $148.23 Mn |
Enteric Empty Capsules Market Forecast 2023 - 2031
Market Overview :
Consegic Business Intelligence analyzes that the Enteric Empty Capsules Market is growing with a CAGR of 8.3% during the forecast period (2023-2031), and the market is projected to be valued at USD 148.23 million by 2031 and USD 78.47 million in 2023 from USD 73.31 million in 2022.
Market Definition :
An enteric empty capsule is a type of capsule that is designed to resist disintegration and dissolution in the stomach. This allows the contents of the capsule to pass through the stomach and into the small intestine, where they are more effectively absorbed. Owing to the coating outside the capsule, the product is widely incorporated in pharmaceutical applications as it is the most common way to achieve acid resistance. The process simplifies drug enteric delivery implementation and allows the ingredients to reach the small intestine for maximum absorption process. Also, the capsules protect the stomach from acidic nature and digestive discomfort. The enteric empty capsules are less likely to cause any gastric side effects such as nausea, stomach upset, and others. The capsules offer better targeted delivery of nutrients to where they are needed most in the human body. Moreover, the products also have longer shelf life than traditional empty capsules.
Market Dynamics :
Drivers :
-
Increasing prevalence of chronic diseases is accelerating the market growth.
Enteric empty capsules are largely essential for providing supplements and medications in treating chronic diseases. Owing to certain features of the capsules such as accurate dosage and compatibility with different kinds of drugs, the enteric empty capsules are largely demanded in treatments for chronic conditions. Moreover, increasing cases of cancer, heart disease, diabetes, respiratory illness, and neurovascular stroke globally are leading to driving the demand for enteric empty capsules market. For instance, in 2021, according to an article by the Centers for Disease Control and Prevention, obesity prevalence in the U.S. was around 41.9% between 2017 to March 2020. Thus, owing to increasing chronic disorders globally due to multiple aforementioned factors, the enteric empty capsules market is growing significantly.
-
Rising demand for nutraceuticals is boosting the market growth.
The enteric empty capsules are regarded as one of the preferred and efficient dosage forms for the delivery of nutraceuticals. The increasing prevalence of noncommunicable diseases such as diabetes, cancer, and others is leading to more demand for capsules for different medications and treatment purposes. For instance, according to a report by Pain American Health Organization in 2022, noncommunicable diseases (NCDs) kill 41 million people each year worldwide, equivalent to 71% of all deaths globally. In America, 5.5 million deaths are by NCD every year. Also, increasing demand for nutraceuticals across the globe is fostering the demand for enteric empty capsules. According to a report by the Ministry of Food Processing Industries in 2021, India's nutraceutical market is prepped to be a global leader at USD 4 to 5 billion by 2025. It is expected to grow approximately to USD 18 billion by 2025. The report also mentions growing demand for immunity-boosting supplements and vitamin capsules is driving more demand for the entry empty capsules. Hence, due to rising demand for nutraceuticals and growing noncommunicable diseases, the enteric empty capsules market is witnessing significant growth.
Restraint :
-
Dietary restrictions is hampering the market growth.
Enteric empty capsules have gelatin as the most common material used in the production process. Gelatin is prepared from collagen, which is made from the by-products of slaughtered animals which include bones, hides, hooves of cattle, fish, pigs, horses, and others. Thus, dietary restrictions for animal-origin-based products by different consumers prove to be a major restraint for hampering the enteric empty capsules market growth. Hence, due to certain dietary restrictions and cultural practices followed by different individuals, the enteric empty capsules market growth is getting hampered to a certain extent.
Opportunities :
-
Advancement in capsule manufacturing technology is expected to boost the market growth.
Different innovations in capsule manufacturing technology such as the development of automated capsule filling machines and others are expected to boost the enteric empty capsules market further. The high efficiency and speed of the automated capsule filling machines is bringing in growing production capacity and reduction in manufacturing costs. Furthermore, innovations in capsule materials such as plant-based capsules are extracting major demand in the market due to the vegetarian-friendly attribute of the product. Thus, different advancements in capsule design and materials by the key players of the market are improving the drug delivery process, enhancing product quality, improving patient compliance, and others. For instance, in 2021, Evonik launched new enteric protected ready-to-fill capsules for fast and high-performance drug development. They launched a new product named EUDRACAP, which is suitable for early drug development stages through a commercial scale and by using sensitive molecules. Hence, different technological innovations in the capsules by the key market players are driving the enteric empty capsules market further in the forecast years.
Enteric Empty Capsules Market Report Coverage :
| Report Attributes | Report Details |
| Study Timeline | 2017-2031 |
| Market Size in 2031 | USD 148.23 Million |
| CAGR (2023-2031) | 8.3% |
| By Type | Gelatin and Non-Gelatin |
| By Therapeutic Application | Antibiotic and Antibacterial Drugs, Antacid and Antiflatulent Preparations, Dietary Supplements, Cardiovascular Therapy Drugs, and Others |
| By End User | Pharmaceutical and Biopharmaceutical Companies, Cosmetic Companies, Nutraceutical Companies, Clinical Research Organizations, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
| Key Players | Lonza Group Ltd, Evonik, The Roxlor Group, CapsCanada Corporation, Qualicaps Inc., CapsulCN International Co., Ltd., Natural Capsules Limited, Snail Pharma Industry Co. Ltd, ACG Group, and Anhui Huangshan Capsule Co., Ltd. |
Get More Information
Download Sample ReportMarket Segmentation :
By Type :
The type segment is categorized into gelatin and non-gelatin. In 2022, the gelatin segment accounted for the highest market share and is expected to grow at the fastest CAGR over the forecast period in the enteric empty capsules market. Owing to the low cost and high availability of gelatin in the market, the gelatin product is witnessing significant growth. Furthermore, the protein content in the gelatin capsules acts as a catalyst for the growth of the gelatin type in the enteric empty capsules market. Moreover, different benefits of the product offering such as increased bioavailability, easy digestion, and others are boosting the growing demand for gelation capsules. Furthermore, gelatin is widely demanded by people suffering from joint and skin disorders. Also, gelatin capsules are largely used in the pharmaceutical and nutraceutical industry for dietary supplements and other medications. Hence, due to the aforementioned advantages of the product, gelatin capsules are witnessing significant growth in the enteric empty capsules market.
By Therapeutic Application :
The therapeutic application segment is categorized into antibiotic and antibacterial drugs, antacid and antiflatulent preparations, dietary supplements, cardiovascular therapy drugs, and others. In 2022, the dietary supplements segment accounted for the highest market share and is expected to grow at the fastest CAGR over the forecast period in the enteric empty capsules. This is due to the increasing demand for dietary supplements owing to the wide availability of the products in the market. Also, increasing health consciousness and a growing focus on personalized nutrition is boosting the growth of dietary supplements. The product is widely used by fitness enthusiasts, body builders, youth as well as aging population for bridging the nutritional gaps and addressing health needs and concerns. Empty capsules are ideal for encapsulation of various powdered supplements such as amino acids, protein powder, pre-workout formulas, and others. Hence, due to the growing dietary supplements market coupled with increasing awareness of healthy lifestyles and changing consumer behavior for lifestyle modification, there is increasing demand for the dietary supplements application. For instance, according to a report by the Ministry of Food Processing Industries, in 2021, the dietary supplements market in India was valued at USD 3924.44 million in 2020 and is expected to reach USD 10,198.57 million by 2026 which is a 22% growth rate year on year. Hence, due to the aforementioned benefits of the application, the dietary supplement segment is witnessing significant growth in the enteric empty capsules market.
By End User :
The end user segment is categorized into pharmaceutical and biopharmaceutical companies, cosmetic companies, nutraceutical companies, clinical research organizations, and others. In 2022, the nutraceutical companies segment accounted for the highest market share of 32.79% in the enteric empty capsules market. An increase in nutraceutical intake to boost immunity and growing consciousness for healthy lifestyle is increasing the demand for the segment. Furthermore, the rapid expansion of the nutraceutical industry coupled with rising consumption of supplement capsules such as minerals, vitamins, and others are driving major demand for the nutraceutical companies segment. For instance, according to a report by Invest India in 2020, the nutraceuticals market is expected to grow from USD 4 billion in 2017 to USD 18 billion in 2025, due to increasing demand for dietary supplements from upper and middle class consumers in India. Hence, due to increasing demand for enteric entry capsules in nutraceutical companies, the segment is witnessing significant growth in the enteric empty capsules market.
Moreover, the cosmetic companies segment is expected to grow at the fastest CAGR in the enteric empty capsules market during the forecast period. Enteric empty capsules are largely used in cosmetic companies for the utilization of the product in treating skin problems and different skin conditions, enhancing the texture of the skin, and improving beauty enrichment. Also, the growing cosmetics industry globally is driving major growth of the enteric empty capsules market. For instance, according to a report in 2023 by Cosmetics Europe, a personal care association, the retail sales price for cosmetic products in the European market was around USD 94 billion in 2022 and is forecasted to increase significantly. The largest national markets for cosmetics and personal care products within Europe are Germany, France, Italy, UK, Spain, and Poland. Hence, due to the increasing cosmetic industry and wide demand for enteric empty capsules in the cosmetic industry, the segment is witnessing significant growth in the enteric empty capsules market.
Get More Information
Download Sample ReportBy Region :
The regional segment includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regional Growth Insights
Download Sample ReportIn 2022, North America accounted for the highest market share at 33.56%, valued at USD 24.60 million in 2022 and USD 26.16 million in 2023, it is expected to reach USD 48.31 Million in 2031. In North America, the U.S. accounted for the highest market share of 86.23% during the base year 2022. This is due to the presence of key players in the region, coupled with advanced healthcare facilities in North America. Also, favorable government initiatives and increasing demand for preventive care in the region is boosting the enteric empty capsule market growth in the region. Advanced treatment options coupled with an established healthcare system act as a catalyst for the growth of the enteric empty capsules market in the region. Hence, due to the aforementioned factors, the enteric empty capsules market is growing significantly in North America.
Moreover, Asia Pacific is expected to witness significant growth over the forecast period, growing at a CAGR of 8.9% during 2023-2031. Growing pharmaceutical and nutraceutical industries in the region is boosting the demand for enteric empty capsules. For instance, according to a report by India Brand Equity Foundation in 2023, the market size of the pharmaceuticals industry in India is expected to reach around USD 65 billion by 2024, and USD 130 billion by 2030. Also, pharmaceutical exports from India reach more than 200 nations around the world. Hence, the increasing pharmaceutical industry is leading to larger growth of the enteric empty capsules market in the region.
Details Countries Growth Insights
Download Sample ReportEnteric Empty Capsules Market Competitive Landscape:
The enteric empty capsules market is highly competitive, with several large players and numerous small and medium-sized enterprises. These companies have strong research and development capabilities and a strong presence in the market through their extensive product portfolios and distribution networks. The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships. The key players in the market include-
- Lonza Group Ltd
- Evonik
- The Roxlor Group
- CapsCanada Corporation
- Qualicaps Inc.
- CapsulCN International Co., Ltd.
- Natural Capsules Limited
- Snail Pharma Industry Co. Ltd
- ACG Group
- Anhui Huangshan Capsule Co., Ltd.
Recent Developments :
- In May 2021, Evonik launched a new platform, called EUDRACAP platform, to help the pharmaceutical industry accelerate the speed to market for complex oral drug products in early development stages. EUDRACAP is Evonik's latest system solution built on the company's unique technology platform for advanced drug delivery.
- In November 2022, Lonza Group Ltd launched an innovative new capsule solution for intestinal (enteric) drug delivery. The product, Enprotect capsule does not disintegrate during stomach transit and only releases its contents in the intestine.
Frequently Asked Question
What was the market size of the enteric empty capsules industry in 2022?+
In 2022, the market size of enteric empty capsules was USD 73.31 million.
What will be the potential market valuation for the enteric empty capsules industry by 2031?+
In 2031, the market size of enteric empty capsules will be expected to reach USD 148.23 million.
What are the key factors driving the growth of the enteric empty capsules market?+
Rising demand for nutraceuticals is fueling market growth at the global level.
What is the dominating segment in the enteric empty capsules market by end user?+
In 2022, the nutraceutical companies segment accounted for the highest market share of 32.79% in the overall enteric empty capsules market.
Based on current market trends and future predictions, which geographical region is the dominating region in the enteric empty capsules market?+
North America accounted for the highest market share in the overall enteric empty capsules market.
Select Licence :
| Single User | : $4200 |
|---|---|
| Multi User | : $6200 |
| Corporate User | : $7400 |
- Online PDF access to 1 user
- Unlimited analyst support
- 20% or 48 hours of free customization
- No expiry to the report
- Online PDF access upto 10 Users
- Unlimited lead analyst support
- 35% or 72 hours of free customization
- No expiry to the report
- Access to downloadable excel data sheet
- All multi user license features plus
- Unlimited user access(within the organization)
- 40% or 96 hours of free customization
- Unlimited download, print & forwards allowed
- 25% discount on your next purchase
